BIAL
Ricardo Lima has extensive experience in the pharmaceutical industry, primarily with BIAL since May 2000, where Ricardo has held numerous leadership roles including Associate Director, CMC, Head of CMC, and CMC Manager. Responsibilities have included team and budget management, coordination of pharmaceutical development activities, management of clinical trial supplies, technology transfer activities, and regulatory support related to quality issues. Additionally, Ricardo served as a Board Member at Ordem dos Farmacêuticos from January 2013 to March 2022. Academic qualifications include a Doctor of Pharmacy degree from the Faculty of Pharmacy - Oporto University and an Executive MBA from Porto Business School, complemented by professional development at the University of California, Berkeley.
This person is not in any offices
BIAL
Founded in 1924, BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 50 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world. Its strategic areas are Innovation, Internationalisation and Quality. Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D programme. The key focus area for the Group is neurosciences. The company headquarters are located in Portugal. BIAL has also facilities in Spain, Germany, United Kingdom, Italy, Switzerland, US, Mozambique, Angola, Panama and Ivory Coast. BIAL Group is a member of the “European Federation of Pharmaceutical Industries and Associations” (EFPIA). BIAL has also been distinguished by its support to several medical and scientific activities, namely through BIAL Foundation, having as outstanding events the BIAL Award in Biomedicine, the Prémio BIAL de Medicina Clínica and Scientific Research Grants, well recognized worldwide. For more information, please visit: www.bial.com For issues of safety or others related to product quality, please contact: pharmacovigilance@bial.com